Filing Manager
Glenn H. Nussdorf
Reporting Manager
Glenn H. Nussdorf
Symbol
ORGO
Shares outstanding
126,273,814 shares
Disclosed Ownership
12,248,560 shares
Ownership
9.7%
Form type
SCHEDULE 13D/A
Filing time
03 Nov 2025, 17:40:52 UTC
Date of event
14 May 2025

Quoteable Key Fact

"Glenn H. Nussdorf disclosed 9.7% ownership in Organogenesis Holdings Inc. Class A Common Stock, par value $0.0001 per share (ORGO) on 14 May 2025."

Quick Takeaways

  • Glenn H. Nussdorf filed SCHEDULE 13D/A for Organogenesis Holdings Inc. Class A Common Stock, par value $0.0001 per share (ORGO).
  • Disclosed ownership: 9.7%.
  • Date of event: 14 May 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 03 Nov 2025, 17:40.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Glenn H. Nussdorf 9.7% 12,248,560 10,994,161 1,254,399 /s/ Glenn H. Nussdorf Glenn H. Nussdorf 0001244191
GN 2016 Family Trust u/a/d August 12, 2016 0.7% 918,680 918,680 0 /s/ Michael W. Katz Michael W. Katz, Trustee 0001757453
GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 6.2% 7,928,570 7,928,570 0 /s/ Michael W. Katz Michael W. Katz, Trustee 0001757452
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .